Latest filing published 01 Feb 2022 for Aerie Pharmaceuticals INC, €5,451.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Kathleen Mcginley: trading record in brief
Kathleen Mcginley (senior executive) discloses dealings in 2 companies, chiefly Ista Pharmaceuticals Inc and Aerie Pharmaceuticals Inc. The record holds 39 filings, for trades running from 16 February 2006 to 30 January 2022.
On the market, this insider has only ever bought: 1 purchase, €2,758 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 17 share grants and 6 option exercises.
The latest filing, published on 1 February 2022, reports a share grant of €5,451 in Aerie Pharmaceuticals Inc. The last purchase on record was published on 11 December 2008, which is 6,541 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kathleen Mcginley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 878 shares@ US$6.92100.0% of flowCommon StockSEC:0001209191-22-005948:0
- 97,508 shares@ US$9.10Common StockSEC:0001181431-12-036823:0
- 14,633 shares@ US$6.77Common StockSEC:0001181431-12-029829:0
- 10,898 shares@ US$9.09Common StockSEC:0001181431-12-029829:1
- 13,338 shares@ US$7.43Common StockSEC:0001181431-12-029829:2
- 10,902 shares@ US$9.09Common StockSEC:0001181431-12-029829:3
- 19,396 shares@ US$4.46Common StockSEC:0001181431-12-029829:4
- 9,517 shares@ US$9.09Common StockSEC:0001181431-12-029829:5
- 13,462 shares@ US$1.04Common StockSEC:0001181431-12-029829:6
- 1,540 shares@ US$9.09Common StockSEC:0001181431-12-029829:7
- 13,458 shares@ US$3.63Common StockSEC:0001181431-12-029829:8
- 5,374 shares@ US$9.09Common StockSEC:0001181431-12-029829:9
- 3,594 shares@ US$6.82Common StockSEC:0001181431-12-029829:10
- 2,696 shares@ US$9.09Common StockSEC:0001181431-12-029829:11
- 22,250 shares0Common StockSEC:0001181431-11-058629:0
- 841 shares@ US$7.48Common StockSEC:0001181431-11-008919:0
- 8,500 shares0Common StockSEC:0001181431-11-008719:0
- 662 shares@ US$6.15COMMON STOCKSEC:0001181431-11-007975:1
- 841 shares@ US$6.20Common StockSEC:0001181431-11-007971:0
- 394 shares@ US$3.96Common StockSEC:0001255823-10-000042:0
- 692 shares@ US$3.63Common StockSEC:0001255823-10-000010:0
- 8,000 shares0Common StockSEC:0001255823-10-000010:1
- 384 shares@ US$1.82Common StockSEC:0001255823-09-000016:0
- 8,000 shares0Common StockSEC:0001255823-09-000006:0
- 5,649 shares@ US$0.6312Common StockSEC:0001255823-08-000031:0Canonical exit: 9 Mar 2009 (T+90)
25 of 32 declarations
